SARS-CoV-1刺突蛋白S2亚基单克隆抗体与新型冠状病毒SARS-CoV-2交叉反应
本研究评估了先前针对SARS-CoV-1刺突蛋白(S蛋白)产生的单克隆抗体(mAbs)与SARS-CoV-2的交叉反应性。序列比对显示SARS-CoV-1 S蛋白S2亚基的一个免疫原性结构域在SARS-CoV-2中高度保守。四种针对该片段的小鼠mAbs能识别哺乳动物细胞系表达的SARS-CoV-2 S蛋白,其中mAb 1A9可检测SARS-CoV-2感染细胞中的S蛋白并适用于夹心ELISA。这些交叉反应mAbs或可作为SARS-CoV-2研究和COVID-19诊断检测开发的工具。
要点
- SARS-CoV-1 S2亚基免疫原性结构域在SARS-CoV-2中高度保守。
- 四种小鼠mAbs可识别细胞系表达的SARS-CoV-2 S蛋白。
- mAb 1A9适用于夹心ELISA检测SARS-CoV-2感染细胞。
核心结论
- 针对SARS-CoV-1 S蛋白S2亚基的交叉反应mAbs可能作为SARS-CoV-2研究和COVID-19诊断检测开发的工具。
研究设计与样本
- 将SARS-CoV-2 S蛋白序列与SARS-CoV-1、MERS及普通感冒冠状病毒进行比对。
- 测试针对SARS-CoV-1 S蛋白的mAbs与SARS-CoV-2或其S蛋白的结合能力,使用SARS-CoV-2感染细胞及表达全长或S2亚基片段的细胞。
- 进行定量ELISA比较mAbs与重组S蛋白的结合。
主要发现
- SARS-CoV-1 S蛋白S2亚基的一个免疫原性结构域在SARS-CoV-2中高度保守,但在MERS和人类普通感冒冠状病毒中不保守。
- 四种针对该免疫原性片段的小鼠mAbs能识别哺乳动物细胞系表达的SARS-CoV-2 S蛋白。
- mAb 1A9可检测SARS-CoV-2感染细胞中的S蛋白,并适用于夹心ELISA形式。
临床怎么用
- 交叉反应mAbs可用于SARS-CoV-2研究。
- mAb 1A9等交叉反应mAbs可用于开发COVID-19诊断检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundA novel coronavirus, SARS-CoV-2, which emerged at the end of 2019 and causes COVID-19, has resulted in worldwide human infections. While genetically distinct, SARS-CoV-1, the aetiological agent responsible for an outbreak of severe acute respiratory syndrome (SARS) in 2002-2003, utilises the same host cell receptor as SARS-CoV-2 for entry: angiotensin-converting enzyme 2 (ACE2). Parts of the SARS-CoV-1 spike glycoprotein (S protein), which interacts with ACE2, appear conserved in SARS-CoV-2.AimThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.MethodsThe SARS-CoV-2 S protein sequence was aligned to those of SARS-CoV-1, Middle East respiratory syndrome (MERS) and common-cold coronaviruses. Abilities of mAbs generated against SARS-CoV-1 S protein to bind SARS-CoV-2 or its S protein were tested with SARS-CoV-2 infected cells as well as cells expressing either the full length protein or a fragment of its S2 subunit. Quantitative ELISA was also performed to compare binding of mAbs to recombinant S protein.ResultsAn immunogenic domain in the S2 subunit of SARS-CoV-1 S protein is highly conserved in SARS-CoV-2 but not in MERS and human common-cold coronaviruses. Four murine mAbs raised against this immunogenic fragment could recognise SARS-CoV-2 S protein expressed in mammalian cell lines. In particular, mAb 1A9 was demonstrated to detect S protein in SARS-CoV-2-infected cells and is suitable for use in a sandwich ELISA format.ConclusionThe cross-reactive mAbs may serve as useful tools for SARS-CoV-2 research and for the development of diagnostic assays for COVID-19.
引用
- Zheng Z, Monteil VM, Maurer-Stroh S, et al. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2. Euro Surveill. 2020. PMID: 32700671. doi:10.2807/1560-7917.ES.2020.25.28.2000291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。